1. Home
  2. FATE vs SUPX Comparison

FATE vs SUPX Comparison

Compare FATE & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

SELL

Current Price

$2.07

Market Cap

260.0M

Sector

Health Care

ML Signal

SELL

Logo Super X AI Technology Limited Ordinary Shares

SUPX

Super X AI Technology Limited Ordinary Shares

HOLD

Current Price

$4.80

Market Cap

273.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
SUPX
Founded
2007
2021
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.0M
273.3M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
FATE
SUPX
Price
$2.07
$4.80
Analyst Decision
Buy
Analyst Count
11
0
Target Price
★ $5.74
N/A
AVG Volume (30 Days)
★ 1.1M
335.2K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.88
N/A
EPS
N/A
★ N/A
Revenue
★ $6,646,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.95
$4.11
52 Week High
$3.23
$53.36

Technical Indicators

Market Signals
Indicator
FATE
SUPX
Relative Strength Index (RSI) 43.74 26.74
Support Level $1.78 N/A
Resistance Level $2.15 $7.40
Average True Range (ATR) 0.13 0.52
MACD 0.02 -0.11
Stochastic Oscillator 60.42 23.26

Price Performance

Historical Comparison
FATE
SUPX

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About SUPX Super X AI Technology Limited Ordinary Shares

Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.

Share on Social Networks: